FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,051,342 | -55.5% | 495,916 | 0.0% | 0.21% | -79.5% |
| Q2 2023 | $2,360,560 | -16.5% | 495,916 | 0.0% | 1.02% | +34.0% |
| Q1 2023 | $2,826,721 | -73.0% | 495,916 | -52.2% | 0.76% | -71.5% |
| Q4 2022 | $10,465,913 | -55.0% | 1,037,256 | 0.0% | 2.67% | -51.5% |
| Q3 2022 | $23,245,000 | -9.6% | 1,037,256 | 0.0% | 5.51% | -5.2% |
| Q2 2022 | $25,703,000 | – | 1,037,256 | – | 5.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |